DailyDoctor Archive Specialties Get app
Back to the 26 October 2026 edition

Research · 03 of 05

Cachexia was linked to more complications after gastrointestinal cancer surgery

Screen for cachexia before gastrointestinal cancer surgery; it was associated with more complications and longer stays.

Design
Systematic review and meta-analysis of cohort studies
Population
27,473 patients with gastrointestinal cancers in 34 studies
Primary outcome
Postoperative complications, chemotherapy toxicity, length of stay
Effect
Postoperative complications OR 1.38 (1.11–1.72); stay +2.09 days (0.91–3.26)

A meta-analysis of 34 cohort studies with 27,473 patients with gastrointestinal cancers examined whether cachexia predicts treatment-related harm. Cachexia was associated with more postoperative complications (OR 1.38, 95% CI 1.11–1.72) and about two extra days in hospital (mean difference 2.09). It was not clearly associated with chemotherapy-related adverse events (OR 1.42, 0.57–3.54).

Heterogeneity was substantial throughout and the certainty of evidence very low, partly because cachexia was defined differently across studies. Radiotherapy toxicity and readmission could not be analysed.

The result supports what most surgeons already suspect, and it is a reason to measure weight loss and muscle mass before surgery rather than a basis for specific risk thresholds.

  • Record weight loss and appetite at the first visit for every gastrointestinal cancer patient.
  • Consider dietetic referral before surgery in patients with cachexia.
  • Factor cachexia into consent discussions about postoperative recovery.
  • No clear link with chemotherapy toxicity was found, but the estimate was imprecise.

Why it matters

Weight loss is easy to record and often missed in the rush to treatment.

Don't overread it

Very-low-certainty, heterogeneous observational data cannot show that treating cachexia reduces complications.

The statistics, in plain English

An odds ratio of 1.38 means about 38% higher odds of complications. For chemotherapy toxicity, the interval from 0.57 to 3.54 crosses 1.0, so no conclusion can be drawn.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

screeninggynoncgicancersupportivebreast

Tomorrow morning, before your first patient

One edition a day for oncology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app